Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences

Apollo expands its growth ecosystem by acquiring a minority stake in pioneering life sciences venture capital firm and providing up to €1 billion of capital commitments Sofinnova Partners poised to accelerate growth with additional capital and global strategic partner NEW YORK & PARIS--(BUSINESS WIRE)--Apollo (NYSE: APO) and Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced a long-term strategic and financial partnership. Under the agreement, Apollo will take a minority equity interest in Sofinnova and commit up to €1 billion of managed capital to its investment funds. This strategic partnership is poised to significantly accelerate Sofinno